» Articles » PMID: 7707527

Molecular Cloning and Characterization of a Cellular Protein That Interacts with the Human Immunodeficiency Virus Type 1 Tat Transactivator and Encodes a Strong Transcriptional Activation Domain

Overview
Journal J Virol
Date 1995 May 1
PMID 7707527
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism by which human immunodeficiency virus type 1 Tat transactivates the long terminal repeat promoter is not understood. It is generally believed that Tat has one or more transcription factors as its cellular target. One might expect a cellular target for Tat to possess several properties, including (i) the ability to bind to the Tat activation region, (ii) the possession of a transcriptional activation domain, and (iii) the ability to contact the cellular transcription machinery. Here we describe the cloning, expression, and characterization of a human protein, termed TAP (Tat-associated protein), which possesses some of these properties. TAP is highly conserved in eukaryotes and is expressed in a variety of human tissues. The major intracellular species of TAP is a highly acidic 209-amino-acid protein that likely is formed by removal of a highly basic 70-amino-acid N-terminal segment from a primary translation product. By deletion analysis, we have identified a TAP C-terminal region rich in acidic amino acids and leucine residues which acts as a strong transcriptional activator when bound through GAL4 sites upstream of the core long terminal repeat promoter, as well as flanking sequences that mask the activation function. Amino acid substitution of two leucine residues within the core activation region results in loss of the TAP activation function. Two lines of evidence suggest that Tat interacts with TAP in vivo. First, promoter-bound Tat can recruit a TAP/VP16 fusion protein to the promoter. Second, transiently expressed Tat is found associated with endogenous TAP, as demonstrated by coimmuno-precipitation analysis. As shown in an accompanying report, the TAP activation region binds the Tat core activation region and general transcription factor TFIIB (L. Yu, P.M. Loewenstein, Z. Zhang, and M. Green, J. Virol. 69:3017-3023, 1995). These combined results suggest the hypothesis that TAP may function as a coactivator that bridges Tat to the general transcription machinery of the cell via TFIIB.

Citing Articles

The Interactions of the Complement System with Human Cytomegalovirus.

Lujan E, Zhang I, Garon A, Liu F Viruses. 2024; 16(7).

PMID: 39066333 PMC: 11281448. DOI: 10.3390/v16071171.


The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb/RNAPII/TAR complex promoting HIV transcription elongation.

Li C, Mori L, Lyu S, Bronson R, Getzler A, Pipkin M Proc Natl Acad Sci U S A. 2022; 120(1):e2217476120.

PMID: 36584296 PMC: 9910500. DOI: 10.1073/pnas.2217476120.


Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cells.

Koo B, Won M, Kim Y, Ryoo S Cardiovasc Res. 2021; 118(5):1344-1358.

PMID: 33964139 PMC: 8953445. DOI: 10.1093/cvr/cvab163.


Overexpressed p32 localized in the endoplasmic reticulum and mitochondria negatively regulates calcium‑dependent endothelial nitric oxide synthase activit.

Choi K, Koo B, Yoon B, Jung M, Yun H, Jeon B Mol Med Rep. 2020; 22(3):2395-2403.

PMID: 32705193 PMC: 7411372. DOI: 10.3892/mmr.2020.11307.


Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy.

DeSimone A, Leszyk J, Wagner K, Emerson Jr C Sci Adv. 2019; 5(12):eaaw7099.

PMID: 31844661 PMC: 6905861. DOI: 10.1126/sciadv.aaw7099.


References
1.
Selby M, Peterlin B . Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell. 1990; 62(4):769-76. DOI: 10.1016/0092-8674(90)90121-t. View

2.
Cullen B . Does HIV-1 Tat induce a change in viral initiation rights?. Cell. 1993; 73(3):417-20. DOI: 10.1016/0092-8674(93)90126-b. View

3.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

4.
Gorman C, Moffat L, Howard B . Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982; 2(9):1044-51. PMC: 369897. DOI: 10.1128/mcb.2.9.1044-1051.1982. View

5.
Green M, Brackmann K, Lucher L, Symington J, Kramer T . Human adenovirus 2 E1B-19K and E1B-53K tumor antigens: antipeptide antibodies targeted to the NH2 and COOH termini. J Virol. 1983; 48(3):604-15. PMC: 255391. DOI: 10.1128/JVI.48.3.604-615.1983. View